Back
Pros Holdings Vs. Blueprint Medicines Industry Stock Comparison
Sell
37
PRO
Pros Holdings
Last Price:
$16.18
Seasonality Move:
-0.31%
Buy
53
BPMC
Blueprint Medicines
Last Price:
$129.46
Seasonality Move:
1.87%
Sell
37
Pros Holdings (PRO)
is a Sell
Is Pros Holdings a Buy, Sell or Hold?
-
The current Pros Holdings [PRO] share price is $15.65. The Score for PRO is 37, which is 26% below its historic median score of 50, and infers higher risk than normal.
-
PRO is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
53
Blueprint Medicines (BPMC)
is a Buy
Is Blueprint Medicines a Buy, Sell or Hold?
-
The current Blueprint Medicines [BPMC] share price is $129.46. The Score for BPMC is 53, which is 6% above its historic median score of 50, and infers lower risk than normal.
-
BPMC is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
PRO Stock Price Chart
What is Pros Holdings's stock price today?
-
The Pros Holdings share price today is $15.65Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and PRO is experiencing slight selling pressure.
BPMC Stock Price Chart
What is Blueprint Medicines's stock price today?
-
The Blueprint Medicines share price today is $129.46Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and BPMC is experiencing slight buying pressure.
PRO Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 4.18 | Buy |
Relative Strength Index (14 RSI): | 45.91 | Sell |
Chaikin Money Flow: | -779704 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (14.71 - 16.21) | Buy |
Bollinger Bands (100): | (15.37 - 20.57) | Sell |
BPMC Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 2.34 | Buy |
Relative Strength Index (14 RSI): | 76.66 | Buy |
Chaikin Money Flow: | 0 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (128.13 - 129.21) | Buy |
Bollinger Bands (100): | (86.05 - 122.97) | Buy |
PRO Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 15.51 | Buy |
20-day SMA: | 15.71 | Sell |
50-day SMA: | 16.8 | Sell |
200-day SMA: | 20.21 | Sell |
8-day EMA: | 14.62 | Buy |
20-day EMA: | 10.46 | Buy |
50-day EMA: | 5.6 | Buy |
200-day EMA: | 1.64 | Buy |
BPMC Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 129.39 | Buy |
20-day SMA: | 128.78 | Buy |
50-day SMA: | 119.98 | Buy |
200-day SMA: | 100.05 | Buy |
8-day EMA: | 129.3 | Buy |
20-day EMA: | 128.05 | Buy |
50-day EMA: | 120.46 | Buy |
200-day EMA: | 103.98 | Buy |
Pros Holdings Earnings Growth & PRO Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.10 per share, a decrease next quarter of $0.03 per share, an increase this year of $0.25 per share, and an increase next year of $0.24 per share.
Blueprint Medicines Earnings Growth & BPMC Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.52 per share, an increase next quarter of $0.48 per share, an increase this year of $0.60 per share, and an increase next year of $1.59 per share.
Pros Holdings Technical Analysis
Jul 9 | Jul 10 | Jul 11 | Jul 14 | Jul 15 | Jul 16 | Jul 17 | Jul 18 | Jul 21 | Jul 22 | |
---|---|---|---|---|---|---|---|---|---|---|
Jul | ||||||||||
09 | 10 | 11 | 14 | 15 | 16 | 17 | 18 | 21 | 22 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Blueprint Medicines Technical Analysis
Jul 9 | Jul 10 | Jul 11 | Jul 14 | Jul 15 | Jul 16 | Jul 17 | Jul 18 | Jul 21 | Jul 22 | |
---|---|---|---|---|---|---|---|---|---|---|
Jul | ||||||||||
09 | 10 | 11 | 14 | 15 | 16 | 17 | 18 | 21 | 22 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |